Tianxin Pharmaceutical: 2024 net profit is expected to rise by 36.85% year-on-year, plans to distribute 10 PI 6.8 yuan.

On April 25, Jin10 reported that Tianxin Pharmaceutical announced that the company achieved an operating income of 2.209 billion yuan in 2024, a year-on-year rise of 17.35%; net profit was 651 million yuan, a year-on-year rise of 36.85%. The company plans to distribute a cash dividend of 6.8 yuan (including tax) for every 10 shares. During 2024, the market prices of products such as Vitamin B6 and Vitamin B1 have increased compared to 2023, which is an important reason for driving the company's performance rise.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments